Bifidobacterium breve inhibits colorectal cancer via extracellular vesicles containing formate acetyltransferase
{{output}}
Background: Colorectal cancer (CRC) is the second leading cause of cancer-related mortality worldwide. The gut microbiota exerts unique therapeutic advantages against CRC, and the probiotic Bifidobacterium breve (B. breve) has be... ...
